The development of rapid and sensitive diagnostic tools is an urgent need in the management of opportunistic serious infections in immunocompromised patients with or without human immunodeficiency virus (HIV) infection. During the 1990's molecular biological techniques have been applied for the rapid detection of infectious agents : nucleic acid hybridization techniques and the polymerase chain reaction (PCR). Mycobacterium tuberculosis (M. tuberculosis) is one of the most important pathogens which is frequently associated with HIV infection. The World Health Organization (WHO) estimates that 1.7 billion inhabitants of the earth are infected with M. tuberculosis, of whom8 million develop active disease and 3 million die annually (1) and that the global incidence of tuberculosis will increase by 57% between 1990 and 2005. The main reason for this increase is the world-wide spread of HIV infection, because dual infection with HIV and M. tuberculosis results in a greatly increased risk of tuberculosis (2). Amplification of target mycobacterial DNAusing PCR offers the possibility of rapid and sensitive detection of mycobacterial infection. This method has already been used by several groups (3-6), and has been shown to facilitate rapid detection of positive samples. One study showed that PCRis highly specific in sputum samples (3). However, most proven tuberculosis samples were smear positive, and the sensitivity in smear-negative, culture-positive patients could not be deduced from this study.
The PCR approach does have drawbacks (7). First, the procedure is costly and laborious. Second, the test is susceptible to false-positive results. In particular, the contamination of samples with mycobacterial DNAor amplification products from prior tests ("carryover") remains an important obstacle to routine use.
Pneumocystis carinii (P. carinii) is another important pathogen which is also frequently involved in pneumonia in the immunocompromisedhost. Especially in AIDSpatients, the incidence and seriousness are very high. Direct detection ofP. carinii by use of toluidine blue O, other simple staining techniques or by fluorescent monoclonal antibodies was found to be very sensitive, specific and rapid with the use of induced sputum or bronchoalveolar lavage fluid (8). A PCRtechnique has been applied for the detection of P. carinii using respiratory secretion and blood as the specimens (9). A simple and rapid 2-step PCR has also been described for the detection of this microorganism (10). These new PCR techniques are likely to be the most useful in the monitoring of sputum for breakthrough infection in patients on prophylactic therapy (1 1).
Cytomegalovirus (CMV)is a ubiquitous virus and possesses widely variabje propensity to cause invasive disease in different host settings. Manifestations of active CMV infection range from asymptomatic viral shedding to retinitis, pneumonia, gastrointestinal ulceration, and disseminated disease ( 1 2).
Several studies have demonstrated that viremia of high grade correlates with invasive disease (13, 14) . But there still remains uncertainity because not all viremic individuals develop disease. Therefore, the diagnosis of active CMVinfection still depends mainly on traditional techniques such as viral isolation and shell vial centrifuge culture assay by staining with monoclonal antibody to the CMVimmediate-early antigen. Recently, rapid detection of CMVby PCR is widely investigated and PCRhas been described to be more sensitive than culture in the detection of the virus in various types of clinical specimens (15, 16). Ishigaki etal (17) proposed that serum PCR positivity is correlated with CMVpneumonia in bone marrow recipients.
CMV and P. carinii are common opportunistic pathogens and often are concurrently involved in pneumonia in immunocompromisedhosts. Weattempted the simultaneous detection of CMV-DNA and P. carinii-DNA using rapid cycle DNA amplification in capillary PCRtesting ( 1 8) and concluded that this method is useful for the rapid and sensitive simultaneous detection of CMV-specific and P. carinii-specific DNAfragments, in order to pursue early initiation of treatment for these infections. Shimomoto et al (19) applied PCR on induced sputum for making the diagnosis of the initial stage of acute pulmonary infections due to three major pathogens, P. carinii, M. tuberculosis and CMV,in hemophilia patients infected with HIV. They conductedPCR 1 1 1 times in 29 patients. Prophylactics againstP. carinii were given to all the patients whose CD4+ count was less than 200x106/l. As a result, P. carinii DNAwas not detected in all of the induced sputum samples. M. tuberculosis -DNAand CMV-DNA, however, were detected in one and four patients, respectively. The results of this study suggest the necessity for prophylactics in the prevention of P. carinii pneumoniain seriously immunocompromised patients and also the need to attempt to simultaneously detect the other two pathogens, M. tuberculosis and CMV,in the same specimen.
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